Efficacy and safety of denosmab in patients with glucocorticoid-induced osteoporosis refractory to combination therapy with bisphosphonate and vitamin D
Latest Information Update: 16 Mar 2020
At a glance
- Drugs Denosumab (Primary) ; Bisphosphonates; Vitamin D
- Indications Corticosteroid-induced osteoporosis
- Focus Therapeutic Use
- 12 Mar 2020 Status changed from active, no longer recruiting to completed.
- 30 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 27 May 2016 New trial record